The Developmental and HyperActive Ras Tumor (DHART) SPORE is a National Cancer Institute (NCI) funded initiative that offers both a Career Enhancement Program (CEP) and a Developmental Research Program (DRP). The CEP is a mentored award for early-stage investigators. The DRP is designed to support established investigators interested in NF1 driven tumors. There are multiple opportunities for collaboration with DHART SPORE investigators and access to core services. Given the overall goal of the DHART SPORE is implementing effective therapies for neoplasms and cancers characterized by germline and somatic NF1 mutations, this opportunity may be of interest to discovery, clinical and population investigators interested in NF1 and Rasopathies. We welcome your application! If you have any questions, please contact Jaishri Blakeley, MD (jblakel3@jhmi.edu).
The Children’s Tumor Foundation is a proud partner of the Developmental HyperActive Ras Tumor (DHART) SPORE program; CTF CEO Annette Bakker sits on the EAB.
SUBMISSION DEADLINE: July 15, 2024
